Jagielski D.: These were the top-selling GLP-1 drugs last quarter from Eli Lilly and Novo Nordisk
Imaging demonstrates various manifestations, including diffuse abnormalities in the supratentorial white matter, reduced brain volume, diffuse cerebral edema, basal ganglia calcifications, and delayed myelination [78, 79]
Cardiovascular Health TRIUMPH-4 data showed meaningful reductions in non-HDL cholesterol, triglycerides, and high-sensitivity C-reactive protein
It helps transport long-chain fatty acids into the mitochondria (the "powerhouses" of your cells), where theyre converted into energy to keep you going
However, due to elevated liver enzymes seen in patients taking the drug during testing, Pfizer said it decided to shed the lotiglipron program and move forward with its twice-daily GLP-1 pill